Literature DB >> 19154631

Association of X-box binding protein 1 ( XBP1) genotype with morning cortisol and 1-year clinical course after a major depressive episode.

Michael F Grunebaum1, Hanga C Galfalvy, Yung-yu Huang, Thomas B Cooper, Ainsley K Burke, Melissa Agnello, Maria A Oquendo, J John Mann.   

Abstract

Brain diseases including Alzheimer's and Parkinson's involve the cellular 'unfolded protein' (UPR) stress response. Psychiatric illnesses such as depressive disorders are thought to involve brain stress-response pathways. The XBP1 gene encodes a key transcription factor in the UPR stress response and therefore could be involved in the pathophysiology of depressive disorders. A functional polymorphism (-116C-->G) in the XBP1 promoter was linked in some studies to bipolar disorder. Among 132 adults (mean age 39 yr) who presented with a major depressive episode, this polymorphism was found to be associated with a worse course during 1-yr prospective follow-up. In a subgroup (n=22), the polymorphism was associated with higher plasma levels of the stress hormone cortisol. The results suggest that hypothalamic-pituitary-adrenocortical and cellular stress pathways involving the XBP1 gene may be involved in the pathophysiology of major depressive disorder. These relationships merit further study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19154631      PMCID: PMC3773868          DOI: 10.1017/S1461145708009863

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  11 in total

Review 1.  Orchestrating the unfolded protein response in health and disease.

Authors:  Randal J Kaufman
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin.

Authors:  Sven Cichon; Silvia Buervenich; George Kirov; Nirmala Akula; Albena Dimitrova; Elaine Green; Johannes Schumacher; Norman Klopp; Tim Becker; Stephanie Ohlraun; Thomas G Schulze; Monja Tullius; Magdalena M Gross; Lisa Jones; Stefan Krastev; Ivan Nikolov; Marian Hamshere; Ian Jones; Piotr M Czerski; Anna Leszczynska-Rodziewicz; Pawel Kapelski; Ann Van Den Bogaert; Thomas Illig; Joanna Hauser; Wolfgang Maier; Wade Berrettini; William Byerley; William Coryell; Elliot S Gershon; John R Kelsoe; Melvin G McInnis; Dennis L Murphy; John I Nurnberger; Theodore Reich; William Scheftner; Michael C O'Donovan; Peter Propping; Michael J Owen; Marcella Rietschel; Markus M Nöthen; Francis J McMahon; Nick Craddock
Journal:  Nat Genet       Date:  2004-08       Impact factor: 38.330

Review 3.  ER stress and neurodegenerative diseases.

Authors:  D Lindholm; H Wootz; L Korhonen
Journal:  Cell Death Differ       Date:  2006-03       Impact factor: 15.828

4.  No gene is an island: the flip-flop phenomenon.

Authors:  Ping-I Lin; Jeffery M Vance; Margaret A Pericak-Vance; Eden R Martin
Journal:  Am J Hum Genet       Date:  2007-01-22       Impact factor: 11.025

Review 5.  Major depressive disorder.

Authors:  R H Belmaker; Galila Agam
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

6.  Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder.

Authors:  Jonathan So; Jerry J Warsh; Peter P Li
Journal:  Biol Psychiatry       Date:  2007-01-09       Impact factor: 13.382

7.  Behavioral stress and activated serotonergic neurotransmission induce XBP-1 splicing in the rat brain.

Authors:  Hiroyuki Toda; Go Suzuki; Masashi Nibuya; Katsutoshi Shioda; Koichi Nishijima; Tomoki Wakizono; Yasunari Kanda; Yasuhiro Watanabe; Kunio Shimizu; Soichiro Nomura
Journal:  Brain Res       Date:  2006-08-02       Impact factor: 3.252

8.  XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.

Authors:  H Yoshida; T Matsui; A Yamamoto; T Okada; K Mori
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

9.  Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder.

Authors:  Chihiro Kakiuchi; Kazuya Iwamoto; Mizuho Ishiwata; Miki Bundo; Takaoki Kasahara; Ichiro Kusumi; Takahiro Tsujita; Yuji Okazaki; Shinichiro Nanko; Hiroshi Kunugi; Tsukasa Sasaki; Tadafumi Kato
Journal:  Nat Genet       Date:  2003-08-31       Impact factor: 38.330

10.  Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism.

Authors:  Yung-yu Huang; Maria A Oquendo; Jill M Harkavy Friedman; Lawrence L Greenhill; Beth Brodsky; Kevin M Malone; Vadim Khait; J John Mann
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

View more
  5 in total

1.  Psychological stress, cocaine and natural reward each induce endoplasmic reticulum stress genes in rat brain.

Authors:  A A Pavlovsky; D Boehning; D Li; Y Zhang; X Fan; T A Green
Journal:  Neuroscience       Date:  2013-05-02       Impact factor: 3.590

2.  Epigenetic differences in monozygotic twins discordant for major depressive disorder.

Authors:  K Malki; E Koritskaya; F Harris; K Bryson; M Herbster; M G Tosto
Journal:  Transl Psychiatry       Date:  2016-06-14       Impact factor: 6.222

Review 3.  Animal models for the study of depressive disorder.

Authors:  Juhyun Song; Young-Kook Kim
Journal:  CNS Neurosci Ther       Date:  2021-03-01       Impact factor: 5.243

4.  Unravelling the GSK3β-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder.

Authors:  Becky Inkster; Andy Simmons; James H Cole; Erwin Schoof; Rune Linding; Tom Nichols; Pierandrea Muglia; Florian Holsboer; Philipp G Sämann; Peter McGuffin; Cynthia H Y Fu; Kamilla Miskowiak; Paul M Matthews; Gwyneth Zai; Kristin Nicodemus
Journal:  Psychiatr Genet       Date:  2018-10       Impact factor: 2.458

5.  Altered Expression of Endoplasmic Reticulum Stress Associated Genes in Hippocampus of Learned Helpless Rats: Relevance to Depression Pathophysiology.

Authors:  Matthew A Timberlake; Yogesh Dwivedi
Journal:  Front Pharmacol       Date:  2016-01-12       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.